KLK12 and prostate carcinoma: These include KLK12 (log2FC 3.2 iCluster3; Fig. 2) and HPN (log2FC 1.6–2.2), which have both been linked with prostate cancer aggressiveness (Lose et al., 2013; Holt et al., 2010).